Rare condition

Amyloidosis

ORPHA:69 ↗

Search all Amyloidosis trialsAlert me when a trial opens

studies recruiting now

checking live

studies registered in total

checking live

countries with a recruiting site

checking live

recruiting study posted to date

checking live

Recruiting trials

Fetching live from ClinicalTrials.gov. This condition is not yet in our weekly snapshot; live results only.

Keep watching

Get an email when a new Amyloidosis study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:69 ↗

A group of conditions, not a single diagnosis

Orphanet classifies “Amyloidosis” as a category that groups several related conditions. Trials are usually registered under the specific condition, so the figures above may undercount. Browse the conditions in this group or see the classification on Orphanet.

Treatments being studied

6 approved treatments and 17 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Ixazomib Citrate (Ninlaro)Approved: Patisiran Sodium (Onpattro)Approved: Tafamidis Meglumine (Vyndaqel)Approved: Inotersen Sodium (Tegsedi)Approved: Tafamidis (Vyndamax)Approved: Patisiran

Phase 3Eprodisate Disodium

Phase 3Birtamimab

Phase 3Lenalidomide (Lenalidomide accord)

Phase 3Revusiran

Phase 3Vutrisiran

Phase 2Iodine I124 Evuzamitide

Phase 2Miridesap

Phase 2Idelalisib (Zydelig)

+ 9 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).